menu
    • menu

    Company profile for Adimab

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all stages to leading acad...
    Adimab is the most successful antibody discovery company in the industry, with 450+ discovery campaigns and 55+ clinical programs created with more than 100 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all stages to leading academic institutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AdimabUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7 Lucent Drive Lebanon, NH 03766
    Telephone
    Telephone
    603.643.7110
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.adimab.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GSK Gets New Approval For Depemokimab With Adimab Collaboration
    GSK Gets New Approval For Depemokimab With Adimab Collaboration

    15 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7181739

    FIRSTWORD PHARMA
    15 Apr 2026
    Share Share
    Adimab Records Year of Double-Digit Clinical Program Growth
    Adimab Records Year of Double-Digit Clinical Program Growth

    13 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/adimab-records-another-year-of-double-digit-clinical-program-growth-302660111.html

    PR NEWSWIRE
    13 Jan 2026
    Share Share
    Adimab Reports Strong Partnering Year for 2025
    Adimab Reports Strong Partnering Year for 2025

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/adimab-reports-strong-partnering-year-for-2025-302658894.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    Adimab Provides Update on Pipeline
    Adimab Provides Update on Pipeline

    14 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250114961789/en

    BUSINESSWIRE
    14 Jan 2025
    Share Share
    Adimab Provides Year-End Update on 2024 Partnership Activities
    Adimab Provides Year-End Update on 2024 Partnership Activities

    13 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250113547780/en

    BUSINESSWIRE
    13 Jan 2025
    Share Share
    Adimab Announces Hire of Aaron Sato as Chief Strategy Officer
    Adimab Announces Hire of Aaron Sato as Chief Strategy Officer

    16 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241016565601/en

    BUSINESSWIRE
    16 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search